MacroGenics
MGNX
#8309
Rank
โ‚น28.56 B
Marketcap
โ‚น449.40
Share price
1.95%
Change (1 day)
286.50%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.77. In 2024 the company made an earnings per share (EPS) of -โ‚น102.09 a decrease over its 2023 EPS that were of -โ‚น14.31.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-95.12%
2024-โ‚น102.09613.33%
2023-โ‚น14.31-92.31%
2022-โ‚น186.06-42.14%
2021-โ‚น321.5536.44%
2020-โ‚น235.68-21.84%
2019-โ‚น301.51-24.58%
2018-โ‚น399.79675.93%
2017-โ‚น51.52-68.05%
2016-โ‚น161.25168.25%
2015-โ‚น60.11-55%
2014-โ‚น133.583400%
2013-โ‚น3.82-108.68%
2012โ‚น43.9824.49%
2011โ‚น35.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.99-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,693-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,382-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น653.59-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น339.42-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น339.68-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น168.88 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA